Early phase-3 results suggest clevidipine safe, effective for some patients

Raible, Eric; Messerli, Franz. H.
April 2008
Cardiology Today;Apr2008, Vol. 11 Issue 4, p27
The article reports the results of a clinical trial for clevidipine, an antihypertensive drug. Findings showed that the drug was effective in treating acute severe hypertension. The drug actively lowered BP in 19 patients with acute hypertension and 24 patients with renal dysfunction. More than 90 percent of renal and hypertension patients enrolled in the study achieved the target BP through the use of the drug.


Related Articles

  • Trial and error. Day, Michael // New Scientist;08/08/98, Vol. 159 Issue 2146, p5 

    Reports that a lack of controlled data for new drugs for high blood pressure is causing concern in Great Britain. Alain Li Wan Po of Nottingham University's involvement in testing the drugs; The question of safety of six centrally acting antihypertensives, which are about to be licensed; How...

  • Valsartan approval for hypertension.  // American Family Physician;5/1/1997, Vol. 55 Issue 6, p2348 

    States that Valsartan has been approved by the U.S. Food and Drug Administration for the first line treatment of hypertension. Mechanism of action of Valsartan drug; Recommended dosage of Valsartan drug and its contraindication.

  • Angiotensin-II Receptor Antagonists: Their Place in Therapy. Kirk, Julienne K.; Sloan, Richard W. // American Family Physician;6/1/1999, Vol. 59 Issue 11, p3140 

    Focuses on the effectiveness of angiotensin-II receptor antagonists in treating hypertension. Several angiotensin-II receptor antagonists labeled for use in hypertension by the United States Food and Drug Administration; Information on the renin-angiotensin-aldosterone system; Mechanism of...

  • Millions of mild hypertensives.  // British Medical Journal;10/18/1980, Vol. 281 Issue 6247, p1024 

    Examines the treatment for mild hypertensive in Great Britain. Management of blood pressure levels; Cautions on the fatal and non-fatal complications; Efficacy of drugs as treatment.

  • Phase II/III.  // Applied Clinical Trials;Jul2005, Vol. 14 Issue 7, p16 

    Provides information related to latest phase II/III clinical trials. Initiation of a trial for an inhalable form of treprostinil for pulmonary hypertension by Lung Rx; Efficacy of Fibrillex at improving symptoms of Amylois A Amyloidosis, based on Neurochem Inc.'s trial.

  • Obese: BP targets 'are not attainable'  // Pulse;10/25/2004, Vol. 64 Issue 42, p21 

    Reports on a study suggesting that use of multiple antihypertensive drugs are ineffective in controlling hypertension in many obese patients. Risk of hypertension among obese patients.

  • Antihypertensive effect of the mineralocorticoid receptor antagonist eplerenone: a pooled analysis of patient-level data from comparative trials using regulatory-approved doses. Fernet, Mireille; Beckerman, Bruce; Abreu, Paula; Lins, Katharina; Vincent, John; Burgess, Ellen // Vascular Health & Risk Management;Sep2018, Vol. 14, p233 

    Purpose: Several options are available for the treatment of hypertension; however, many treated patients are still not below blood pressure (BP) target. Eplerenone, a selective mineralocorticoid receptor antagonist, is an approved treatment option for the management of patients with...

  • A NEW BASE LINE FOR THE EVALUATION OF ANTIHYPERTENSIVES. Grenfell, Raymond F.; Briggs, Arthur H.; Holland, William C. // Angiology;Nov1962, Vol. 13 Issue 11, p495 

    In the parenteral placebo group, there was a significant decrease in the systolic blood pressure for 63 weeks and in the diastolic blood pressure for 147 weeks when compared to the blood pressure in week 0 of treatment. There was a significant decrease in the systolic blood pressure in these...

  • Randomized clinical trials of antihypertensive drugs: all that glitters is not gold. McAlister, Finlay A.; Straus, Sharon; Sackett, David; McAlister, F A; Straus, S; Sackett, D // CMAJ: Canadian Medical Association Journal;09/08/98, Vol. 159 Issue 5, p488 

    Editorial. Criticizes research in this issue regarding the use of losartan or amlodipine for the treatment of hypertension. Research by Wilson et al in this issue; Internal validity of the research; Use of randomized clinical trials (RCTs); Limits to the clinical applicability of the research;...

  • Adherence to antihypertensive medication and association with patient and practice factors. Inkster, M. E.; Donnan, P. T.; MacDonald, T. M.; Sullivan, F. M.; Fahey, T. // Journal of Human Hypertension;Apr2006, Vol. 20 Issue 4, p295 

    The article identifies effective interventions to enhance patient medication adherence to antihypertensive medication. Adherence relates to ability and willingness to abide by a prescribed therapeutic regimen. The finding suggests that adherence to antihypertensive medication is higher than...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics